SCHEMBL19736247

SCHEMBL19736247

COc1ccc(/C=C2\SC(=S)N(C(C)C(=O)O)C2=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.69
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
ALDH1A1 P00352 4/20 0.69
CRHBP P24387 1/20 0.69
CRHR2 Q13324 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
PTPN1 P18031 2/20 0.65
NCOA3 Q9Y6Q9 1/20 0.60
BCL2 P10415 5/20 0.60
MCL1 Q07820 3/20 0.60
BCL2L1 Q07817 1/20 0.60
BAK1 Q16611 1/20 0.60
LMNA P02545 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
THRB P10828 1/20 0.57
BCL2L2 Q92843 3/20 0.56
DUSP22 Q9NRW4 1/20 0.55
BAD Q92934 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29408609 1.00 MAPT (0.69) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL25997992 0.86 MAPT (0.67) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL17769038 0.86 MEN1 (0.73) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL29408635 0.85 PTPN1 (0.64) MAPTMEN1KMT2AALDH1A1PTPN1
SCHEMBL19736048 0.85 PTPN1 (0.64) MAPTMEN1KMT2AALDH1A1PTPN1
SCHEMBL6884827 0.84 PTPN1 (0.67) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL6884831 0.84 PTPN1 (0.67) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL15709086 0.80 MEN1 (0.60) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL15709085 0.80 MEN1 (0.60) MAPTMEN1KMT2AALDH1A1CRHBP
SCHEMBL18103043 0.78 MAPT (0.75) MAPTMEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468555-B1 COMPOSITIONS FOR USE IN TREATING BACTERIAL INFECTIONS VERSITECH LTD (HK) 2023-08-09 EP disclosed
US-20190307729-A1 ANTIMICROBIAL COMPOUNDS AND METHODS FOR USE THEREOF VERSITECH LIMITED (HK) 2019-10-10 US disclosed
WO-2017215552-A1 ANTIMICROBIAL COMPOUNDS AND METHODS FOR USE THEREOF THE UNIVERSITY OF HONG KONG (CN) 2017-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190307729-A1 ANTIMICROBIAL COMPOUNDS AND METHODS FOR USE THEREOF NRDC, NISCH, NEK5 MAPT 2108/4885MEN1 1047/4885KMT2A 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.